# Ernexa Therapeutics Inc.: Form SC 13D/A, filed Jun 5, 2019

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D/A
- Filed: 2019-06-05
- Accepted by EDGAR: Jun 5, 2019, 17:19 ET
- Period: not reported
- Accession: 0001213900-19-010117
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000121390019010117/sc13d0619a1ellin_ntnbuzztime.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000121390019010117/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000121390019010117/sc13d0619a1ellin_ntnbuzztime.htm

Filed Jun 5, 2019.
Source: SEC EDGAR, the filing index for accession 0001213900-19-010117. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.